Treatment of Vitiligo With the 308-nm Xenon Chloride Excimer Laser
December 2002
in “
Archives of Dermatology
”
Studysummary This abstract contains no research results; it provides information about the JAMA Dermatology journal and its access options.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
The study from 2002 focused on the use of the 308-nm xenon chloride (XeCl) excimer laser for treating vitiligo in six patients. Treatments were administered twice weekly, starting with an initial dose of 49.5 mJ/cm², which was increased incrementally. Out of the six patients, four completed the 6-month treatment, with repigmentation typically starting by the eighth week and varying rates of success; one patient achieved 95% repigmentation while another achieved less than 50%. The mean cumulative dose was 50.7 J/cm². Side effects were mild, including erythema and pruritus. The study concluded that the XeCl excimer laser is a promising and potentially preferable treatment for localized vitiligo.
